Stryker’s Chart Says ‘Buy’

Popular Posts:

• 6 Stocks to Sell in May
• In My 45 Years in the Market, I Have Never Seen Anything Like This
• Top 6 Stocks to Buy for May

Recent Posts:

• Have We Seen the Highs for the Summer?
• Homebuilder on the Verge of a Double-Top Breakout
• Will the Key Reversal Day Be the Market’s Kiss of Death?
• View All Posts

Stryker Corp. (NYSE:SYK) — This medical supply company offers a diverse array of medical technologies, including reconstructive, surgical, neurotechnology and spine products. It has had steady growth through acquisitions, the latest being the neurovascular division of Boston Scientific.

Its expected 10%-plus earnings growth for 2013 would put it in line to earn $4.50 per share versus $4.12 in 2012.

Technically SYK broke out from a head-and-shoulders bottom (reverse head-and-shoulders) on Friday with a price target of $62.

Click to Enlarge